Kolesnikov O. L. (Doctor of Medical Sciences, Professor, FSBEI HE South-Urals State Medical University MOH Russia (Chelyabinsk))
Kolesnikova A. A. (Ph.D. in Medical Sciences, Associate Professor, FSBEI HE South-Urals State Medical University MOH Russia (Chelyabinsk))
Tarabrina Iu. O. (Ph.D. in Medical Sciences, Associate Professor, FSBEI HE South-Urals State Medical University MOH Russia (Chelyabinsk))
|
Sodium-glucose cotransporter type 2 inhibitors are a new class of antidiabetic drugs. These compounds inhibit the activity of the NLRP3 inflammasome. They also reduce the functional activity of immune system cells and the production of pro-inflammatory cytokines (TNF, IL-1, IL-6). These drugs reduce the expression of a number of genes associated with the development of inflammation. These effects indicate the presence of an anti-inflammatory effect in sodium-glucose cotransporter type 2 inhibitors.
Keywords:sodium-glucose cotransporter, inhibitor, inflammation, inflammasome, interleukin
|
|
|
Read the full article …
|
Citation link: Kolesnikov O. L., Kolesnikova A. A., Tarabrina I. O. Anti-inflammatory effect of sodium-glucose cotransporter‑2 inhibitors (literature review) // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2021. -№09. -С. 120-124 DOI 10.37882/2223-2966.2021.09.15 |
|
|